Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (961-970 of 1,011) with videos related to

Pageof 102
Sort By:
Nature Medicine|May 29, 2012
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METHéctor Peinado, Maša Alečković, Simon Lavotshkin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 21, 2022
Effects of Bardoxolone Methyl in Alport SyndromeBradley A Warady, Pablo E Pergola, Rajiv Agarwal, et al.
Hypertension (Dallas, Tex. : 1979)|November 2, 2016
Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to HydrochlorothiazideErika Salvi, Zhiying Wang, Federica Rizzi, et al.
Circulation. Genomic and Precision Medicine|April 14, 2018
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses)Caitrin W McDonough, Oyunbileg Magvanjav, Ana C C Sá, et al.
Hypertension (Dallas, Tex. : 1979)|June 12, 2013
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazideStephen T Turner, Eric Boerwinkle, Jeffrey R O'Connell, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2021
Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary MelanomasAlexander N Shoushtari, Walid K Chatila, Arshi Arora, et al.
The New England Journal of Medicine|June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPaul B Chapman, Axel Hauschild, Caroline Robert, et al.
Journal of Hypertension|October 2, 2015
PTPRD gene associated with blood pressure response to atenolol and resistant hypertensionYan Gong, Caitrin W McDonough, Amber L Beitelshees, et al.
The Lancet. Oncology|February 11, 2014
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label studyGrant A McArthur, Paul B Chapman, Caroline Robert, et al.
Pageof 102

Showing results (961-970 of 1,011) with videos related to

Sort By:
Pageof 102
Nature Medicine|May 29, 2012
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METHéctor Peinado, Maša Alečković, Simon Lavotshkin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 21, 2022
Effects of Bardoxolone Methyl in Alport SyndromeBradley A Warady, Pablo E Pergola, Rajiv Agarwal, et al.
Hypertension (Dallas, Tex. : 1979)|November 2, 2016
Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to HydrochlorothiazideErika Salvi, Zhiying Wang, Federica Rizzi, et al.
Circulation. Genomic and Precision Medicine|April 14, 2018
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses)Caitrin W McDonough, Oyunbileg Magvanjav, Ana C C Sá, et al.
Hypertension (Dallas, Tex. : 1979)|June 12, 2013
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazideStephen T Turner, Eric Boerwinkle, Jeffrey R O'Connell, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2021
Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary MelanomasAlexander N Shoushtari, Walid K Chatila, Arshi Arora, et al.
The New England Journal of Medicine|June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPaul B Chapman, Axel Hauschild, Caroline Robert, et al.
Journal of Hypertension|October 2, 2015
PTPRD gene associated with blood pressure response to atenolol and resistant hypertensionYan Gong, Caitrin W McDonough, Amber L Beitelshees, et al.
The Lancet. Oncology|February 11, 2014
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label studyGrant A McArthur, Paul B Chapman, Caroline Robert, et al.
Pageof 102